184 related articles for article (PubMed ID: 9134044)
1. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
3. Regulation of complement membrane attack complex formation in myocardial infarction.
Väkevä A; Laurila P; Meri S
Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
[TBL] [Abstract][Full Text] [Related]
4. Expression of 20 KD homologous restriction factor of complement on myocardial cells: an immunohistochemical study using acetone-fixed and paraffin-embedded tissues.
Tada T; Okada H; Okada N; Tateyama H; Eimoto T
J Histochem Cytochem; 1993 Jan; 41(1):119-22. PubMed ID: 7678023
[TBL] [Abstract][Full Text] [Related]
5. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.
Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S
Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561
[TBL] [Abstract][Full Text] [Related]
6. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.
Väkevä A; Laurila P; Meri S
Immunology; 1993 Oct; 80(2):177-82. PubMed ID: 8262547
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
8. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.
Väkevä A; Lehto T; Takala A; Meri S
Scand J Immunol; 2000 Oct; 52(4):411-4. PubMed ID: 11013013
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on the immunohistochemical detection of early myocardial damage.
Ortmann C; Pfeiffer H; Brinkmann B
Int J Legal Med; 2000; 113(4):215-20. PubMed ID: 10929237
[TBL] [Abstract][Full Text] [Related]
10. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
11. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.
Tamai H; Matsuo S; Fukatsu A; Nishikawa K; Sakamoto N; Yoshioka K; Okada N; Okada H
Clin Exp Immunol; 1991 May; 84(2):256-62. PubMed ID: 1709070
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion.
Nijmeijer R; Krijnen PA; Assink J; Klaarenbeek MA; Lagrand WK; Veerhuis R; Visser CA; Meijer CJ; Niessen HW; Hack CE
Eur J Clin Invest; 2004 Dec; 34(12):803-10. PubMed ID: 15606722
[TBL] [Abstract][Full Text] [Related]
13. Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Okada N; Okada H; Miki Y
Clin Exp Immunol; 1990 Nov; 82(2):355-8. PubMed ID: 2242615
[TBL] [Abstract][Full Text] [Related]
14. The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization.
Schnabolk G; Tomlinson S; Rohrer B
Adv Exp Med Biol; 2014; 801():435-40. PubMed ID: 24664728
[TBL] [Abstract][Full Text] [Related]
15. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
[TBL] [Abstract][Full Text] [Related]
16. Complement membrane attack complex and protectin (CD59) in liver allografts during acute rejection.
Lautenschlager I; Höckerstedt K; Meri S
J Hepatol; 1999 Sep; 31(3):537-41. PubMed ID: 10488715
[TBL] [Abstract][Full Text] [Related]
17. Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20.
Okada N; Harada R; Taguchi R; Okada H
Biochem Biophys Res Commun; 1989 Oct; 164(1):468-73. PubMed ID: 2803313
[TBL] [Abstract][Full Text] [Related]
18. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
[TBL] [Abstract][Full Text] [Related]
19. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
Schäfer H; Mathey D; Hugo F; Bhakdi S
J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
[TBL] [Abstract][Full Text] [Related]
20. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
